[Omnic (tamsulosin) in the treatment of benign prostatic hyperplasia].
N A
NA
Lopatkin
Iu A
IuA
Pytel'
M F
MF
Trapeznikova
O B
OB
Loran
E B
EB
Mazo
V N
VN
Stepanov
A A
AA
Gres'
N E
NE
Savchenko
A F
AF
Vozianov
V M
VM
Babich
D000284:Administration, Oral; D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage*; D015415:Biomarkers / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood; D011470:Prostatic Hyperplasia / Q000097:blood / Q000188:drug therapy*; D012449:Safety; D013449:Sulfonamides / Q000008:administration & dosage*; D000077409:Tamsulosin
D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D015415:Biomarkers; D013449:Sulfonamides; D017430:Prostate-Specific Antigen; D000077409:Tamsulosin